Caliway Biopharmaceuticals Co., Ltd. announced a oversubscribed private placement that it has issued 8,000,000 new shares at a price of $12.5 per share for the gross proceeds of $100 million on December 16, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
417.5 TWD | +0.97% | +0.97% | +118.30% |
1st Jan change | Capi. | |
---|---|---|
+118.30% | 1.78B | |
+42.69% | 750B | |
+34.11% | 606B | |
-6.87% | 356B | |
+18.74% | 326B | |
+6.76% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+2.64% | 167B |
- Stock Market
- Equities
- 6919 Stock
- News Caliway Biopharmaceuticals Co., Ltd.
- Caliway Biopharmaceuticals Co., Ltd. announced that it has received $100 million in funding